Kalaris Therapeutics, Inc. Common Stock
$2.92
▼ 0.15
(-4.89%)
Volume: 49,251
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -28.4%
- MA aligned bearish
- RSI 24 oversold
🎯
Pullback
72
- RSI 24 near lows
- Near lower Bollinger band
- -15.6% vs 20MA
💎
Value
58
- -75% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)24.0
MACD-0.031
MA trendBearish
ATR7.16%
21d mom.-28.4%
63d mom.-32.4%
vs 20MA-15.6%
RVOL(20)0.73×
52w low · 3
52w high · 12
-75.4% from 52-week high
20d support 3
· resistance 4
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$73M
PER—
PBR1.27
PSR—
EPS$-1.86
ROE-76.8%
ROA-44.5%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-0.63
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -8.75% | -28.43% | -32.41% | -49.83% | -35.54% | -64.82% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -25.13%, daily vol 2.46%. Kalaris Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.